SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Lazare who wrote (146)10/25/1997 3:19:00 PM
From: John McCarthy  Read Replies (2) of 569
 
Dan -

<< While waiting to see the doctor I had a long conversation
with a fellow who was waitning to have his second of
three shots.

He was amazed with the progress after the first shot.

He had been prepared to look for progress only after the third shot.

Before the first shot he was barely able to walk.

When I saw him he had a slightlimp.

The doctor told me he has given approximately 300 treatments,
with a success rate of approximately 70%.

By success rate I suppose he meant significant progress. >>

Thanks for the feedback.

If you don't mind, I have a question.

The fact that this doctor ALREADY had done 300 treatments, does
this mean that AHP is ALREADY marketing Synvisc?

The Bioxmatrix qtr report indicated AHP would begin to sell
in the 4th qtr.

Thanks again for your feedback, and I sincerely hope your
tennis game gets back to 100% of your potential.

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext